Viewing Study NCT03909295


Ignite Creation Date: 2025-12-24 @ 1:49 PM
Ignite Modification Date: 2026-06-26 @ 5:56 AM
Study NCT ID: NCT03909295
Status: TERMINATED
Last Update Posted: 2021-10-08
First Post: 2019-04-08
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: An Open-label Extension Study Evaluating Safety and Tolerability of LCZ696 in Subjects Who Completed PARAGON-HF in Japan.
Sponsor: Novartis Pharmaceuticals
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: CLCZ696D1301E1
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators